Skip to main content
Figure 5 | BMC Health Services Research

Figure 5

From: A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand

Figure 5

Cost-effectiveness acceptability curve for unrelated HSCT compared with BT-ICT. These graphs demonstrate the probabilities of each intervention being cost-effective at different ceiling ratios, classified by age (year) at the start of treatment. (A) Patient aged 1 year, and (B) Patient aged 10 years. Dashed lines represent the willingness to pay thresholds for the adoption of health interventions in Thailand. BT-ICT: blood transfusion combined with subcutaneous iron chelating therapy; HSCT: hematopoietic stem cell transplantation; QALY: quality adjusted life year; and THB: Thai baht.

Back to article page